Ribavirin dosage in patients with HCV genotypes 2 and 3 who completed short therapy with peg-interferon alpha-2b and ribavirin

Research output: Contribution to journalJournal articleResearchpeer-review

A. Mangia, O. Dalgard, N. Minerva, H. Verbaan, D. Bacca, Helmer Ring Larsen, M. Copetti, V. Caretta, V. Piazzollla, R. Cozzolongo, L. Mottola, A. Andriulli

Original languageEnglish
JournalAlimentary Pharmacology and Therapeutics
Issue number12
Pages (from-to)1346-53
Number of pages7
Publication statusPublished - 1 Jun 2010

ID: 33788360